Jr, W., Robinson, B., Gagel, R., Dralle, H., Fagin, J., Santoro, M., . . . Schlumberger, M. (2012). Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply.
芝加哥风格引文Jr, W., et al. Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply. 2012.
MLA引文Jr, W., et al. Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply. 2012.
警告：这些引文格式不一定是100％准确.